Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:1756-1759
Published online before print September 23, 2002, doi: 10.1161/01.CIR.0000035240.92015.E4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/14/1756    most recent
01.CIR.0000035240.92015.E4v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beeri, R.
Right arrow Articles by Hajjar, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beeri, R.
Right arrow Articles by Hajjar, R. J.
Related Collections
Right arrow Echocardiography
Right arrow Gene therapy

(Circulation. 2002;106:1756.)
© 2002 American Heart Association, Inc.


Brief Rapid Communications

New Efficient Catheter-Based System for Myocardial Gene Delivery

Ronen Beeri, MD; J. Luis Guerrero, BS; Gregory Supple, BS; Suzanne Sullivan, BS; Robert A. Levine, MD; Roger J. Hajjar, MD

From the Cardiovascular Research Center and Cardiac Ultrasound Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Roger J. Hajjar, MD, Cardiovascular Research Center, Massachusetts General Hospital, 149 13th St, CNY4, Charlestown, MA 02129. E-mail rhajjar{at}partners.org

Background— Manipulating gene expression in the failing heart has therapeutic promise, but until now efficient and homogeneous cardiac gene delivery has required an open-chest approach. This study examines the hypothesis that vector delivery promoted by echo contrast microbubbles will be maximized by injection of the vectors into the aortic root with brief balloon occlusion above the sinuses, while at the same time prolonging diastole and vasodilating with acetylcholine (ACh) to maximize coronary exposure.

Methods and Results— After incubation with albumin-coated perfluorocarbon microbubbles, an adenovirus encoding a reporter gene was infused into the aortic root of rats. To maximize delivery, the aortic root was transiently occluded with a balloon catheter during a brief ACh-induced asystole. Ultrasound was used to image the delivery and disrupt the microbubbles. Aortic occlusion with concomitant ACh increased myocardial gene expression for virus + microbubbles by >2.5-fold, from 925±165 to 2358±376 relative units (RU; P<0.01). This delivery system also produced substantial expression with vector alone (1473±549 RU). All uptakes were significant compared with 433±332 RU without virus.

Conclusions— An adenoviral delivery system combining echo contrast with a catheter-based technique to maximize coronary perfusion increases gene delivery compared with echo contrast alone. This novel method permits efficient percutaneous gene delivery in closed-chest animals.


Key Words: gene therapy • echocardiography • catheterization




This article has been cited by other articles:


Home page
J Ultrasound MedHome page
X. Li, Z. Wang, H. Ran, X. Li, Q. Yuan, Y. Zheng, J. Ren, L. Su, W. Zhang, Q. Li, et al.
Experimental Research on Therapeutic Angiogenesis Induced by Hepatocyte Growth Factor Directed by Ultrasound-Targeted Microbubble Destruction in Rats
J. Ultrasound Med., March 1, 2008; 27(3): 453 - 460.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. J. Muller, H. A. Katus, and R. Bekeredjian
Targeting the heart with gene therapy-optimized gene delivery methods
Cardiovasc Res, February 1, 2007; 73(3): 453 - 462.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. Vancraeynest, X. Havaux, A.-C. Pouleur, A. Pasquet, B. Gerber, C. Beauloye, P. Rafter, L. Bertrand, and J.-L. J. Vanoverschelde
Myocardial delivery of colloid nanoparticles using ultrasound-targeted microbubble destruction
Eur. Heart J., January 2, 2006; 27(2): 237 - 245.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. Kondo, K. Ohmori, A. Oshita, H. Takeuchi, S. Fuke, K. Shinomiya, T. Noma, T. Namba, and M. Kohno
Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: The first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction
J. Am. Coll. Cardiol., August 4, 2004; 44(3): 644 - 653.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. M. Roth, N. C. Lai, M. H. Gao, J. D. Drumm, J. Jimenez, J. R. Feramisco, and H. K. Hammond
Indirect intracoronary delivery of adenovirus encoding adenylyl cyclase increases left ventricular contractile function in mice
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H172 - H177.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P D Lambiase and M S Marber
Myocardial gene and cell delivery
Heart, January 1, 2004; 90(1): 1 - 2.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
H-D Liang and M J K Blomley
The role of ultrasound in molecular imaging
Br. J. Radiol., December 1, 2003; 76(suppl_2): S140 - S150.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. J. Giordano
Retrograde coronary perfusion: a superior route to deliver therapeutics to the heart?
J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1129 - 1131.
[Full Text] [PDF]